OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
Marc W. Manseau, Donald Goff
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 816-824
Open Access | Times Cited: 50
Marc W. Manseau, Donald Goff
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 816-824
Open Access | Times Cited: 50
Showing 26-50 of 50 citing articles:
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders
Caitlin Yee, Anees Bahji, María Lolich, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 2, pp. 198-208
Closed Access | Times Cited: 11
Caitlin Yee, Anees Bahji, María Lolich, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 2, pp. 198-208
Closed Access | Times Cited: 11
Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review
Raúl Felipe Palma-Álvarez, Albert Soriano-Día, Elena Ros-Cucurull, et al.
Journal of Dual Diagnosis (2021) Vol. 17, Iss. 2, pp. 159-171
Closed Access | Times Cited: 11
Raúl Felipe Palma-Álvarez, Albert Soriano-Día, Elena Ros-Cucurull, et al.
Journal of Dual Diagnosis (2021) Vol. 17, Iss. 2, pp. 159-171
Closed Access | Times Cited: 11
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline-Trospium Combination: A Systematic Review
Octavian Vasiliu, Beatrice Budeanu, Mihai Stefan Catanescu
(2024)
Open Access | Times Cited: 1
Octavian Vasiliu, Beatrice Budeanu, Mihai Stefan Catanescu
(2024)
Open Access | Times Cited: 1
Effects of the cannabinoid receptor 1 positive allosteric modulator GAT211 and acute MK-801 on visual attention and impulsivity in rats assessed using the five-choice serial reaction time task
Timothy J. Onofrychuk, Shuang Cai, Dan L. McElroy, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 109, pp. 110235-110235
Closed Access | Times Cited: 10
Timothy J. Onofrychuk, Shuang Cai, Dan L. McElroy, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 109, pp. 110235-110235
Closed Access | Times Cited: 10
<p>Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions</p>
Julia Woo, Emma A. van Reekum, Tea Rosic, et al.
Adolescent Health Medicine and Therapeutics (2020) Vol. Volume 11, pp. 53-61
Open Access | Times Cited: 9
Julia Woo, Emma A. van Reekum, Tea Rosic, et al.
Adolescent Health Medicine and Therapeutics (2020) Vol. Volume 11, pp. 53-61
Open Access | Times Cited: 9
Substance Use Disorders and Schizophrenia
Marc W. Manseau, Michael P. Bogenschutz
FOCUS The Journal of Lifelong Learning in Psychiatry (2016) Vol. 14, Iss. 3, pp. 333-342
Open Access | Times Cited: 8
Marc W. Manseau, Michael P. Bogenschutz
FOCUS The Journal of Lifelong Learning in Psychiatry (2016) Vol. 14, Iss. 3, pp. 333-342
Open Access | Times Cited: 8
The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials
Alexandre Seillier
Neuroscience Letters (2021) Vol. 759, pp. 136064-136064
Closed Access | Times Cited: 8
Alexandre Seillier
Neuroscience Letters (2021) Vol. 759, pp. 136064-136064
Closed Access | Times Cited: 8
Epigenetics and the role of nutraceuticals in health and disease
Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 11, pp. 28480-28505
Closed Access | Times Cited: 2
Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 11, pp. 28480-28505
Closed Access | Times Cited: 2
Mismatch negativity as an early biomarker of cognitive impairment in schizophrenia
Abeer Mamdouh Ali Mahmoud, Mai Abd-Elraoof Eissa, Enaas Ahmad Kolkaila, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 2
Abeer Mamdouh Ali Mahmoud, Mai Abd-Elraoof Eissa, Enaas Ahmad Kolkaila, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 2
Genetic association study of psychotic experiences in UK Biobank
Sophie E. Legge, Hannah Jones, Kimberley Kendall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 4
Sophie E. Legge, Hannah Jones, Kimberley Kendall, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 4
Genetic and environmental factors in the etiology of schizophrenia - towards mainstreaming
Agnieszka Łaba-Stefanek, Ewelina Dziwota, Marcin Olajossy
Current Problems of Psychiatry (2016) Vol. 17, Iss. 4, pp. 243-249
Open Access | Times Cited: 2
Agnieszka Łaba-Stefanek, Ewelina Dziwota, Marcin Olajossy
Current Problems of Psychiatry (2016) Vol. 17, Iss. 4, pp. 243-249
Open Access | Times Cited: 2
STUDY ON THE LEVEL OF KNOWLEDGE ABOUT MEDICAL MARIJUANA AMONG MEDICAL STUDENTS
Arkadiusz Bielski, Aleksandra Hus, Anna Sadowska, et al.
Wiadomości Lekarskie (2020) Vol. 73, Iss. 4, pp. 648-656
Open Access | Times Cited: 3
Arkadiusz Bielski, Aleksandra Hus, Anna Sadowska, et al.
Wiadomości Lekarskie (2020) Vol. 73, Iss. 4, pp. 648-656
Open Access | Times Cited: 3
Cannabis Use and Mental Health: Paradoxes of Medicalization
William Dolphin, Michelle Newhart
Springer eBooks (2022), pp. 245-287
Closed Access | Times Cited: 2
William Dolphin, Michelle Newhart
Springer eBooks (2022), pp. 245-287
Closed Access | Times Cited: 2
Особенности аддиктивных расстройств и аффективной симптоматики при шизофрении
А. А. Овчинников, A. N. Sultanova, А.С. Станкевич, et al.
Сибирский вестник психиатрии и наркологии (2021), Iss. 2(111)
Open Access | Times Cited: 2
А. А. Овчинников, A. N. Sultanova, А.С. Станкевич, et al.
Сибирский вестник психиатрии и наркологии (2021), Iss. 2(111)
Open Access | Times Cited: 2
An Introduction to the Complex Connection Between Cannabis and Schizophrenia
Marc W. Manseau, Michael T. Compton
Elsevier eBooks (2017), pp. 1-7
Closed Access | Times Cited: 1
Marc W. Manseau, Michael T. Compton
Elsevier eBooks (2017), pp. 1-7
Closed Access | Times Cited: 1
Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
Serena Deiana, Erica Zamberletti
Elsevier eBooks (2017), pp. 309-339
Closed Access | Times Cited: 1
Serena Deiana, Erica Zamberletti
Elsevier eBooks (2017), pp. 309-339
Closed Access | Times Cited: 1
Cannabis use and schizophrenia development: which are the links?
Júlio Torales, Antonio Ventriglio, Giovanna Vitrani, et al.
Anales de la Facultad de Ciencias Médicas (Asunción) (2017) Vol. 50, Iss. 2, pp. 95-102
Open Access | Times Cited: 1
Júlio Torales, Antonio Ventriglio, Giovanna Vitrani, et al.
Anales de la Facultad de Ciencias Médicas (Asunción) (2017) Vol. 50, Iss. 2, pp. 95-102
Open Access | Times Cited: 1
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
Nicolas Garel, Kyle T. Greenway, Ridha Joober
Journal of Psychiatry and Neuroscience (2021) Vol. 46, Iss. 1, pp. E164-E165
Open Access | Times Cited: 1
Nicolas Garel, Kyle T. Greenway, Ridha Joober
Journal of Psychiatry and Neuroscience (2021) Vol. 46, Iss. 1, pp. E164-E165
Open Access | Times Cited: 1
Inhibitors of Endocannabinoids’ Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice
Marta Kruk-Słomka, Bartlomiej Adamski, Tomasz Słomka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11400-11400
Open Access
Marta Kruk-Słomka, Bartlomiej Adamski, Tomasz Słomka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11400-11400
Open Access
Impactul consumului de canabis asupra semnelor neurologice minore la pacienţii cu schizofrenie
Cristian Petrescu, Diana M. Petrescu, Constantin Alexandru Ciobanu, et al.
Psihiatru ro (2023) Vol. 2, Iss. 1, pp. 16-20
Open Access
Cristian Petrescu, Diana M. Petrescu, Constantin Alexandru Ciobanu, et al.
Psihiatru ro (2023) Vol. 2, Iss. 1, pp. 16-20
Open Access
Desenvolvimento de diferentes métodos LC-MS/MS para a determinação de fármacos e endocanabinóides em amostras de plasma
Vinicius Ricardo Acquaro
(2018)
Open Access
Vinicius Ricardo Acquaro
(2018)
Open Access
Quelle est la place de la consommation de substances dans les troubles psychotiques émergents ?
Mohammed Taleb, Saad Benamar, C. Keddache
Elsevier eBooks (2019), pp. 71-81
Closed Access
Mohammed Taleb, Saad Benamar, C. Keddache
Elsevier eBooks (2019), pp. 71-81
Closed Access
Avaliação das possíveis interações entre o canabidiol e a ayahuasca em voluntários saudáveis: um estudo randomizado, duplo-cego e controlado com placebo
Giordano Novak Rossi
(2020)
Open Access
Giordano Novak Rossi
(2020)
Open Access
Therapeutic management of substance use disorders (II)
Octavian Vasiliu, Ileana Marinescu, D. Vasile
Psihiatru ro (2020) Vol. 1, Iss. 60, pp. 14-14
Open Access
Octavian Vasiliu, Ileana Marinescu, D. Vasile
Psihiatru ro (2020) Vol. 1, Iss. 60, pp. 14-14
Open Access
Treatments with cannabinoids and brain development
Patrícia Schönhofen, Daiani Machado de Vargas, Richard B. Parsons, et al.
Elsevier eBooks (2021), pp. 405-417
Closed Access
Patrícia Schönhofen, Daiani Machado de Vargas, Richard B. Parsons, et al.
Elsevier eBooks (2021), pp. 405-417
Closed Access
